论文信息 - Cancer Therapy : Clinical Phase I Study of Ipilimumab , an Anti – CTLA-4 Monoclonal Antibody , in Patients with Relapsed and Refractory B-Cell Non – Hodgkin Lymphoma - 字舞流文

Cancer Therapy : Clinical Phase I Study of Ipilimumab , an Anti – CTLA-4 Monoclonal Antibody , in Patients with Relapsed and Refractory B-Cell Non – Hodgkin Lymphoma

T. Habermann | S. Ansell | I. Lowy | C. Erlichman | J. Timmerman | B. Laplant | S. Hurvitz | B. Kabat | Patricia A. Koenig | D. Fernando | D. Inwards | M. Verma | R. Yamada